• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Wockhardt Ltd.
    12 Aug 2025
    1428.20
    0.88%
    Wockhardt Eyes Healthy Bottom Line' In Coming Quarters Amid US Tariff Concerns
    Wockhardt Eyes Healthy Bottom Line' In Coming Quarters Amid US Tariff Concerns
    NDTV Profit
    The company recently announced its exit from the loss-making US generics business.
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd. has gained 23.60% in the last 6 Months
    logo
    Sai Life Science Ltd.
    11 Aug 2025
    833.80
    -1.34%
    Sai Life Sciences shares surge 11% in 2 days on strong Q1 earnings
    Business Standard
    The rally in the share price of Sai Life Sciences comes after the company swung back to report a profit of 60 crore in Q1FY26
    Copy LinkShare onShare on Share on Share on
    Promoters unpledged 2.66% of shares in last quarter. Total pledge stands at 0.01% of promoter holdings
    logo
    Biocon Ltd.
    11 Aug 2025
    351.15
    -0.40%
    Biocon shares slip 3% as Q1 results miss estimates; should you sell?
    Business Standard
    Biocon shares fell 3 per cent after it reported a 95.2 per cent decline in net profit in Q1FY26
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 305 to 333 in Jun 2025 qtr.
    logo
    Mankind Pharma Ltd.
    09 Aug 2025
    2549.00
    1.11%
    Mankind Pharma Confident GLP-1 Won't Dent Anti-Diabetic Portfolio Growth
    Mankind Pharma Confident GLP-1 Won't Dent Anti-Diabetic Portfolio Growth
    NDTV Profit
    Even if shifts occur within the anti-diabetes segment, such as therapies moving from the top to the bottom of the market pyramid, Mankind expects to remain stable.
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd.'s price crossed above 200Day SMA today
    logo
    Biocon Ltd.
    08 Aug 2025
    351.15
    -0.40%
    Confident about Biocon's response to US tariffs: Kiran Mazumdar-Shaw
    Business Standard
    We remain confident in our global footprint and are well positioned to respond once more details are available. , said Biocon Chairperson
    Copy LinkShare onShare on Share on Share on
    Promoters have decreased holdings from 60.64% to 54.45% in Jun 2025 qtr
    Biocon's profitability to improve as structured equity exits ease interest burden: Kiran Mazumdar-Shaw
    Business Line | 08 Aug 2025
    logo
    Wockhardt Ltd.
    08 Aug 2025
    1428.20
    0.88%
    Wockhardt's Q1 net loss widens to 108 crore
    Business Line
    Revenue in Q1 stood at 738 crore, as compared to 739 crore in the same period last year
    Copy LinkShare onShare on Share on Share on
    Promoters unpledged 2.60% of shares in last quarter. Total pledge stands at 15.64% of promoter holdings
    Wockhardt Q1 Results: Loss Widens To Rs 108 Crore
    NDTV Profit | 08 Aug 2025
    logo
    Biocon Ltd.
    07 Aug 2025
    351.15
    -0.40%
    Biocon Q1 results: Net profit down 95%, revenue rises 15% to 4,022 cr
    Business Standard
    Biocon's Q1 net profit declines sharply due to high base from one-time gain last year; biosimilars, CRDMO and generics drive revenue and operational growth
    Copy LinkShare onShare on Share on Share on
    Mutual Funds have increased holdings from 8.77% to 15.24% in Jun 2025 qtr.
    Biocon Q1 Results: Profit Slumps 95% Even As Revenue Rises
    NDTV Profit | 07 Aug 2025
    logo
    Lupin Ltd.
    07 Aug 2025
    1893.40
    -0.24%
    Broker's call: Lupin (Buy)
    Business Line
    PL Capital
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading below all available SMAs
    Lupin Q1 Review: Dolat Capital Maintains 'Add', But Cuts Target Price Here's Why
    NDTV Profit | 07 Aug 2025 3 more
    Lupin shares advance 5% after Q1 results; should you buy in?
    Business Standard | 07 Aug 2025
    Lupin Q1 Review: Goldman Sachs Remains Neutral, Hikes Target Price
    NDTV Profit | 07 Aug 2025
    As US tariffs loom, Lupin looks at measures to mitigate impact
    Business Line | 06 Aug 2025
    logo
    Emcure Pharmaceuticals Ltd.
    07 Aug 2025
    1386.50
    0.35%
    Emcure Pharmaceuticals posts 41% growth in profit in Q1
    Business Line
    International business remained a key growth driver, growing 22.1 per cent to 1,106 crore
    Copy LinkShare onShare on Share on Share on
    Emcure Pharmaceuticals Ltd.'s price crossed below 50Day SMA today
    Emcure Pharma Q1 Results: Net Profit Up 41% At Rs 215 Crore
    NDTV Profit | 07 Aug 2025
    logo
    Lincoln Pharmaceuticals Ltd.
    07 Aug 2025
    557.10
    2.53%
    Lincoln Pharma Q1 Results: Net Profit Rises 17%
    Lincoln Pharma Q1 Results: Net Profit Rises 17%
    NDTV Profit
    Lincoln Pharmaceuticals reported a net profit of Rs 27.7 crore for the April-June quarter.
    Copy LinkShare onShare on Share on Share on
    Lincoln Pharmaceuticals Ltd. is trading above its 50 day SMA of 552.9
    Lincoln Pharma Q1 results: Profit up 17% to 28 cr, share jumps 8.5%
    Business Standard | 07 Aug 2025
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd